Potomac Capital Management, Inc.

Position in CDXS — Codexis, Inc.

CIK 1418746 NEW YORK, NY

Position in CDXS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$446,946

-$42,054 QoQ

Shares Held

274,200

-8.6% QoQ

Ownership

0.302%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Potomac Capital Management, Inc. holds $3,783,690 across 3 Biotechnology names. CDXS ranks #3 (11.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GANX	Gain Therapeutics, Inc.	1,008,600	$1,956,684
2	FENC	Fennec Pharmaceuticals Inc.	224,400	$1,380,060
3	CDXS	Codexis, Inc. This page	274,200	$446,946

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$446,946	274,200	-8.6%	Shares	Sole	2026-05-14
2025-12-31	$489,000	300,000	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.